Slide 1Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research` Rury R. Holman, MB, ChB, FRCP Professor of Diabetic Medicine Director, Diabetes Trials Unit,…

Slide 1Vague Presentations John Lord Slide 2 Slide 3 Slide 4 In Pairs Discuss and write down the types of vague illness or vague presentations that confuse you or irritate…

Slide 1 Sessão Clínica UTI coronariana Clinical Round Coronary ICU R2 Dr Priscilla Marques M.D. Slide 2 Severe Left Ventricular Heart Failure in Young Woman with Sustained…

1. Hypoglycemia and Cardiovascular EventsChoosing right therapies and targets, and the right patient Mathew John EndocrinologistProvidence Endocrine & Diabetes Specialty…

Slide 1 Disclosures / Conflicts of Interest Alfred K. Cheung, M.D. None relevant to this topic Slide 2 Slide 3 Lipid Control Is it really needed in the ESRD patient? ESRD:…

Journal Club Journal Club Hallie Lee PharmD Candidate 2013 Mercer University COPHS PHA 618 Geriatrics-Continuous Care Multivitamins in the Prevention of Cardiovascular Disease…

25-OH Vitamin D Levels in a Community Based Primary Care Office in Western New York By Ryan Weber D.O. Background Vitamin D has become widely studied and has been implicated…

Journal Club Journal Club Hallie Lee PharmD Candidate 2013 Mercer University COPHS PHA 618 Geriatrics-Continuous Care Multivitamins in the Prevention of Cardiovascular Disease…

Glycemic Control: When the Lower is Not the âBetterâ? Stefano Genovese UO di Endocrinologia e Diabetologia Ninth International Symposium HEART FAILURE & Co. Rozzano…

Ann F. Chou, PhD, MPH Carol S. Weisman, PhD Rosaly Correa-de-Araujo, MD, PhD Sarah H. Scholle, DrPH, MPH Investigating Gender Differences in HEDIS Measures Related to Heart…